RCMI Coordinating Center (RCMI CC) Header Logo

Connection

José F. Rodríguez-Orengo to Disease Progression

Back to Details
This is a "connection" page, showing publications José F. Rodríguez-Orengo has written about Disease Progression.
José F. Rodríguez-Orengo
Connection Strength
0.178
Disease Progression
  1. Rodr?guez-Torres M, Rodr?guez-Orengo JF, R?os-Bedoya CF, Fern?ndez-Carbia A, Marxuach-Cu?tara AM, L?pez-Torres A, Jim?nez-Rivera J. Effect of hepatitis C virus treatment in fibrosis progression rate (FPR) and time to cirrhosis (TTC) in patients co-infected with human immunodeficiency virus: a paired liver biopsy study. J Hepatol. 2007 Apr; 46(4):613-9.
    View in: PubMed
    Score: 0.063
  2. Rodr?guez-Torres M, R?os-Bedoya CF, Rodr?guez-Orengo J, Fern?ndez-Carbia A, Marxuach-Cu?tara AM, L?pez-Torres A, Salgado-Mercado R, Br?u N. Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus coinfection and along gender. J Clin Gastroenterol. 2006 Apr; 40(4):358-66.
    View in: PubMed
    Score: 0.059
  3. Br?u N, Salvatore M, R?os-Bedoya CF, Fern?ndez-Carbia A, Paronetto F, Rodr?guez-Orengo JF, Rodr?guez-Torres M. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol. 2006 Jan; 44(1):47-55.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support